Abstract Background and Aims Thromboprophylaxis use in paediatric inflammatory bowel
disease [IBD] is inconsistent. Current guidelines only support treating children with acute …

Objective: In patients with inflammatory bowel disease (IBD), the risk of thromboembolism
(TE) is increased, representing a relevant cause of morbidity and mortality. In contrast to …

Objectives: Pediatric inpatients with inflammatory bowel disease (IBD) are rarely considered
for thromboprophylaxis because of concerns about safety and underappreciation of …

Abstract Background and Aims Guidelines regarding thromboprophylaxis for venous
thromboembolisms [VTEs] in children with inflammatory bowel disease [IBD] are based on …

The risk of venous thromboembolism (VTE) is significantly increased in patients with
inflammatory bowel disease (IBD). For the adult population, prophylaxis guidelines exist to …

Venous thromboembolism [VTE] is a recognised serious complication of inflammatory bowel
disease [IBD]. Robust data on the incidence of VTE in children with IBD have however been …

Venous thromboembolism (VTE) is a known complication in children with inflammatory
bowel disease (IBD). Despite awareness of the increased thrombosis risk in this population …

Objectives: Inflammatory bowel disease (IBD) is associated with increased risk of venous
thromboembolism (VTE). Despite this recognized risk, there are limited data and no …

Background Recommendations for venous thromboembolism (VTE) prophylaxis in patients
with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific risk …

Objectives: In addition to gastrointestinal symptoms, pediatric inflammatory bowel disease
(pIBD) may present with extra-intestinal manifestations including venous thromboembolism …